Skip to main content
. 2019 May 21;25(19):2354–2364. doi: 10.3748/wjg.v25.i19.2354

Figure 1.

Figure 1

Rate of patients achieving the different therapeutic endpoints after 12 wk of anti-tumor necrosis factor therapy in 40 patients with Crohn’s disease. CDAI: Crohn’s disease activity index; CRP: C-reactive protein; Fcal: Faecal calprotectin; TNF: Tumor necrosis factor.